Sort
27,075 grants matching “cholesterol”
Project 1: Roles of wild-type and mutant forms of p53 in cancer cell biology
$338,838Carol Prives · Columbia Univ New York Morningside · P01 · FY2020 · CA
Project 1: Roles of wild-type and mutant forms of p53 in cancer cell biology
$338,838Carol Prives · Columbia Univ New York Morningside · P01 · FY2017 · CA
Phase I Study of the BikDD Nanoparticle for Advanced Cancer of the Pancreas
$338,800Milind Javle · University Of Tx Md Anderson Can Ctr · R21 · FY2009 · CA
Lipids in Human Brain Disease
$338,770Stanley I Rapoport · National Institute On Aging · ZIA · FY2013 · AG
GENOMIC RESOURCE DEVELOPMENT IN THE LABORATORY OPOSSUM
$338,666Southwest Foundation For Biomedical Res · R24 · FY2002 · RR
Electrostatic potentials and biological membranes
$338,636Stuart G McLaughlin · State University New York Stony Brook · R01 · FY2007 · GM
Electrostatic potentials and biological membranes
$338,636Stuart G McLaughlin · State University New York Stony Brook · R01 · FY2008 · GM
Paramyxovirus F protein mediated membrane fusion
$338,626Rebecca E. Dutch · University Of Kentucky · R01 · FY2016 · AI
Paramyxovirus F protein mediated membrane fusion
$338,626Rebecca E. Dutch · University Of Kentucky · R01 · FY2017 · AI
Paramyxovirus F protein mediated membrane fusion
$338,626Rebecca E. Dutch · University Of Kentucky · R01 · FY2019 · AI
Lipid Transfer Mechanisms
$338,625Baylor College Of Medicine · R01 · FY2005 · HL
Lipid Transfer Mechanisms
$338,625Baylor College Of Medicine · R01 · FY2004 · HL
Endocrine disruptor mediated activation of PXR causes dyslipidemia
$338,625Changcheng Zhou · University Of Kentucky · R01 · FY2016 · ES
Lipid Transfer Mechanisms
$338,625Baylor College Of Medicine · R01 · FY2003 · HL
Endocrine disruptor mediated activation of PXR causes dyslipidemia
$338,625Changcheng Zhou · University Of Kentucky · R01 · FY2015 · ES
Endocrine disruptor mediated activation of PXR causes dyslipidemia
$338,625Changcheng Zhou · University Of Kentucky · R01 · FY2017 · ES
CELLULAR BASIS OF ANTIATHEROGENESIS BY APOLIPOPROTEIN E
$338,585University Of Pennsylvania · R01 · FY2000 · HL
CYTOLYSIN-MEDIATED TRANSLOCATION IN S. PYOGENES VIRULENC
$338,580Michael G. Caparon · Washington University · R01 · FY2014 · AI
CYTOLYSIN-MEDIATED TRANSLOCATION IN S. PYOGENES VIRULENC
$338,580Michael G. Caparon · Washington University · R01 · FY2012 · AI
CYTOLYSIN-MEDIATED TRANSLOCATION IN S. PYOGENES VIRULENC
$338,580Michael G. Caparon · Washington University · R01 · FY2011 · AI
Pre-clinical Testing of a Novel Therapeutic for Nonalcoholic Steatohepatitis
$338,549Joel Thomas Dudley · Icahn School Of Medicine At Mount Sinai · UH2 · FY2017 · TR
Lipid Microdomains and HIV-1 Replication
$338,546Eric Freed · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
THE CHEMOKINE RECEPTOR CXCR-2 IN ATHEROSCLEROSIS
$338,545Scripps Research Institute · R01 · FY2000 · HL
Cholesterol Sensitivity and Mechanisms of MSC Responses to 3D Substrate Rigidity
$338,452Rocky S. Tuan · University Of Pittsburgh At Pittsburgh · R01 · FY2016 · EB
Mechanisms of Substrate Reduction Therapy for Niemann-Pick C Disease
$338,383Kostantin Dobrenis · Albert Einstein College Of Medicine · R01 · FY2013 · NS